Target discovery through QIAGEN IPA and HSMD

May 13, 2022
Identifying and studying the genomic characteristics of drug targets and important genes are of great interest to many researchers as it can offer new insights into improving drug discovery and precision medicine. In this 90-minute training, QIAGEN Human Somatic Mutation Database (HSMD) will be introduced for genomic investigation. HSMD is a web-based database containing data for hundreds of thousands of variants within the context of solid tumors and hematological malignancies. Specifically, HSMD provides gene-level, alteration-level, and disease-level information including clinically observed gene and variant frequencies across diseases. Accordingly, this webinar will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and HSMD to identify key regulators in ‘omic data and study the genomic characteristics and landscape of both target and disease.

Attendees will learn how to:
• Use IPA to identify key regulators within a dataset of interest
• Use HSMD to investigate variants for target genes and diseases of interest
• Synthesize key findings from drug labels, clinical trials, and PubMed articles for specific alterations and diseases

Related videos


Somatic variants investigation in critical regulatory pathways

87 views August 25, 2022

This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and...


Accelerate R&D in New Cancer Drug Development: A Translational Research Use-case and Discussion

49 views January 10, 2023

The paradigm of predictive biomarkers of therapeutic responses to drug...


Expanding Germline and Somatic Variant Knowledge and Interpretation

171 views September 08, 2022

In this 60-minute webinar, learn how the online resources of the Human Gene...

Gene Variant Databases

Identify meaningful mutations in somatic tumor testing

693 views February 14, 2022

From Information Overload to Actionable Insights Precision medicine is...